Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
30
NCT02052492
Safety Study of EF-022 ( Modified Vitamin D Binding Protein Macrophage Activator) in Subjects With Advanced Solid Tumors
Phase: Phase 1
Role: Lead Sponsor
Start: May 31, 2014
Completion: May 31, 2017
NCT02854761
Safety Study of EF-022 in Adults With Recurrent Respiratory Papillomatosis (RRP)
Start: Sep 30, 2016
Completion: Not specified